Gianfranco F. Ferraccioli

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 189 publications

Has the time come to change the treatment criteria for patients with chronic kidney disease? The "hypofiltering nephron" hypothesis.

Has the time come to change the treatment criteria for patients with chronic kidney disease? The "hypofiltering nephron" hypothesis.

Journal: Frontiers in nephrology

Published: September 25, 2025

Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.

Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.

Journal: Journal of clinical medicine

Published: March 09, 2025

Autoimmune inflammation as a key risk factor for heart failure with preserved ejection fraction: the different types of inflammation driving to HFpEF.

Autoimmune inflammation as a key risk factor for heart failure with preserved ejection fraction: the different types of inflammation driving to HFpEF.

Journal: Frontiers in medicine

Published: January 08, 2025

Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry.

Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry.

Journal: Therapeutic advances in musculoskeletal disease

Published: October 23, 2024

B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory Study.

B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory Study.

Journal: International journal of molecular sciences

Published: February 10, 2024

Difficult to treat rheumatoid arthritis: Sequential therapy with different personalized biological targets could be an option.

Difficult to treat rheumatoid arthritis: Sequential therapy with different personalized biological targets could be an option.

Journal: European journal of internal medicine

Published: January 09, 2024

CAR T-cell perspectives in lupus.

CAR T-cell perspectives in lupus.

Journal: Lancet (London, England)

Published: December 02, 2023

Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.

Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.

Journal: Clinical and experimental rheumatology

Published: September 05, 2023

Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice.

Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice.

Journal: Journal of clinical medicine

Published: August 19, 2023

Severe hand deformities in an undertreated condition.

Severe hand deformities in an undertreated condition.

Journal: European journal of internal medicine

Published: June 15, 2023

Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs.

Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs.

Journal: Clinical and experimental rheumatology

Published: February 08, 2023

COVID-19 illness: Different comorbidities may require different immunological therapeutic targets.

COVID-19 illness: Different comorbidities may require different immunological therapeutic targets.

Journal: European journal of clinical investigation

Published: January 25, 2023

Showing 1-12 of 189

Last Updated: 09/26/2026